 |
|
 |
 The MELISA® MEDICA Foundation is dedicated to the science of metal allergy and its diagnosis when treating so-called "incurable" diseases such as Chronic Fatigue Syndrome (CFS or ME), Multiple Sclerosis (MS) or other autoimmune and allergic diseases.
The MELISA® test is the only scientifically-proven blood test which diagnoses metal allergy. It was originally developed for the diagnosis of occupational allergies at Astra Pharmaceuticals (now AstraZeneca).
Annually, the foundation organises an international conference; The MELISA Study Group. Next meeting will be held in Barcelona in September 2008, and this will be the 14th conference of its kind.
Currently, the foundation is actively involved in research with major universities and dental schools such as:
- The Institute of Dental Research First Medical Faculty at Charles University in Prague, Czech Republic
- The Academic Centre for Dentistry in Amsterdam (ACTA), Holland
- Queen's Hospital, Burton-on-Trent, United Kingdom
It is a not-for-profit organisation with three aims:-
- To use the MELISA® technology for research to examine the role of metals in chronic diseases.
- To help explain and promote the field of metal allergy through conferences and research
- To persuade a charity or government that this technology, which has been successfully used on thousands patients, represents a breakthrough in treating diseases like CFS and MS. The science is proven; MELISA® is waiting to be put to the test.
The MELISA® Foundation's directors include Romuald Hudecek, one of the world's leading experts in amalgam removal and metal-free dentistry, and Dr Birgitta Brunes, a general practitioner, who herself recovered from Multiple Sclerosis and has written about her experience.
|
Printer Friendly Version.
|
 |
